Holen Sie sich die Stockscreener-App
0.4655
0.85%
-0.004
Handel nachbörslich:
.46
-0.0055
-1.18%
Schlusskurs vom Vortag:
$0.4695
Offen:
$0.4577
24-Stunden-Volumen:
2.42M
Relative Volume:
0.43
Marktkapitalisierung:
$71.39M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-122.20M
KGV:
-0.2049
EPS:
-2.272
Netto-Cashflow:
$-86.81M
1W Leistung:
-3.02%
1M Leistung:
+11.26%
6M Leistung:
-54.36%
1J Leistung:
-61.37%
1-Tages-Spanne:
$0.44
$0.4699
1-Wochen-Bereich:
$0.44
$0.5039
52-Wochen-Spanne:
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Firmenname
Fractyl Health Inc
Sektor
Branche
Telefon
781-902-8800
Adresse
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.4655 | 72.01M | 3,000 | -122.20M | -86.81M | -2.272 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-08-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-02-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-27 | Eingeleitet | BofA Securities | Buy |
| 2024-02-27 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Does Fractyl Health Inc have pricing powerMarket Growth Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Fractyl Health announces proposed public offering - MSN
Aug Reactions: What is the dividend yield of Fractyl Health IncWeekly Stock Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
GUTS Technical Analysis & ETF Price Forecast - Intellectia AI
GUTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fractyl Health Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Ionis Pharmaceuticals (IONS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Fractyl Health completes randomization in Remain-1 pivotal cohort of Revita® - marketscreener.com
Fractyl Completes Randomization in REMAIN-1 Revita Trial - TipRanks
Fractyl Health Completes Randomization In Remain-1 Pivotal Cohort Of Revita® - TradingView
Fractyl Health completes randomization in REMAIN-1; topline 6-month data due early Q4 2026 - TradingView
Fractyl Health (GUTS) hits Revita pivotal trial milestone, eyes 2026 FDA filing - Stock Titan
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewswire
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita for Post-GLP-1 Weight Maintenance - Bitget
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat
What is the PEG ratio of Fractyl Health Inc.July 2025 Technicals & Expert-Curated Trade Recommendations - mfd.ru
Alyeska discloses 4.97% Fractyl Health (GUTS) stake in ownership filing - Stock Titan
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Increases By 22.6% - MarketBeat
Insider Sell: What is the dividend yield of Fractyl Health IncJuly 2025 Final Week & AI Driven Price Predictions - baoquankhu1.vn
Decliners Report: How correlated is Fractyl Health Inc to the S P5002025 Momentum Check & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Technicals: Does Fractyl Health Inc have pricing powerJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Even endpoint hits don’t spare shares in three weight-loss updates - BioCentury
Why Fractyl Health Inc. stock remains a top recommendationJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
Market Trends: Is Fractyl Health Inc benefiting from interest rate changesJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Pricey healthcare stocks with halting momentumlow momentum and high valuation (AIM:NYSE) - Seeking Alpha
Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA PlanHas The Bull Case Changed? - simplywall.st
Fractyl Health Shares Fall After Morgan Stanley Downgrade - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fractyl Health, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your Rights – GUTS - marketscreener.com
Institutional Owners May Take Dramatic Actions as Fractyl Health, Inc.'s (NASDAQ:GUTS) Recent 72% Drop Adds to One-year Losses - 富途牛牛
Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics - Yahoo Finance
Revita treatment shows promise for weight maintenance after GLP-1 use By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results - Investing.com India
What if Oprah Knew About Fractyl Health? - MedCity News
Why Is Fractyl Health Stock Tumbling Today?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health's Revita reduces post-GLP-1 weight regain by ~70% - TechTarget
Crude Oil Surges 3%; Caterpillar Shares Gain After Q4 Results - Benzinga
Fractyl Health announces compelling 6-month randomized Remain-1 midpoint data showing durable weight maintenance with Revita after GLP-1 discontinuation - marketscreener.com
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Fractyl’s Revita reduces post-GLP-1 weight regain 70% - BioWorld MedTech
GUTS: Revita cut post-GLP-1 weight regain by 70% in high-risk patients at six months, with strong safety - TradingView
US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings - Benzinga
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? - Stocktwits
Finanzdaten der Fractyl Health Inc-Aktie (GUTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):